Skip to main content
. 2020 Aug 18;10:1372. doi: 10.3389/fonc.2020.01372

Figure 2.

Figure 2

The diagnostic performance of circulating EV-miR-193a-5p as biomarkers in colorectal cancer (CRC). (A) Evaluation of EV-miR-193a-5p as a predictive biomarker in CRC vs. colorectal adenoma (CA)+non-cancerous control (NC), and CRC+CA vs. NC. (B) Evaluation of EV-miR-193a-5p as a predictive biomarker in CRC vs. CA, CRC vs. NC, and stage II/III CRC vs. NC. (C) Comparison between EV-miR-193a-5p and the model-integrated EV-miR-193a-5p and age in predicting CRC from CA+NC. (D) Comparison between EV-miR-193a-5p and the model-integrated EV-miR-193a-5p and age in predicting CRC from NC.